Stocks and Investing Stocks and Investing
Thu, August 10, 2023
Wed, August 9, 2023

Samantha Semenkow Maintained (BEAM) at Strong Buy with Decreased Target to $56 on, Aug 9th, 2023


Published on 2024-10-28 05:44:49 - WOPRAI, Samantha Semenkow
  Print publication without navigation


Samantha Semenkow of Citigroup, Maintained "Beam Therapeutics Inc." (BEAM) at Strong Buy with Decreased Target from $60 to $56 on, Aug 9th, 2023.

Samantha has made no other calls on BEAM in the last 4 months.



There is 1 other peer that has a rating on BEAM. Out of the 1 peers that are also analyzing BEAM, all agrees with Samantha's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $42 on, Thursday, May 11th, 2023